We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

47 hedge funds and large institutions have $5.24M invested in Marker Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

4% more funds holding

Funds holding: 45 → 47 (+2)

0.11% less ownership

Funds ownership: 2.45% → 2.34% (-0.11%)

31% less capital invested

Capital invested by funds: $7.56M → $5.24M (-$2.32M)

Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$58.4K
2
Osaic Holdings
Osaic Holdings
Arizona
+$9.58K
3
TSS
Two Sigma Securities
New York
+$6.46K
4
Jane Street
Jane Street
New York
+$4.27K
5
Renaissance Technologies
Renaissance Technologies
New York
+$4.04K

Top Sellers

Rank Fund Capital Flow
1
AAM
AR Asset Management
California
-$103K
2
BCM
Bridgeway Capital Management
Texas
-$92K
3
MAA
Matrix Asset Advisors
New York
-$51.8K
4
UBS Group
UBS Group
Switzerland
-$14.8K
5
Two Sigma Investments
Two Sigma Investments
New York
-$13.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$4.23K -$13.1K -3,805 -71%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.19K – – –
US Bancorp
28
US Bancorp
Minnesota
$3.56K – – –
Jane Street
29
Jane Street
New York
$3.29K +$4.27K +1,237 New
CFS
30
CRA Financial Services
New Jersey
$3.06K – – –
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$3K – – –
AWP
32
Ascent Wealth Partners
New York
$2.73K +$3.54K +1,027 New
BAM
33
Belpointe Asset Management
Nevada
$2.66K +$3.45K +1,000 New
GSIAS
34
Garden State Investment Advisory Services
New Jersey
$2.66K +$3.45K +1,000 New
TRCT
35
Tower Research Capital (TRC)
New York
$2K +$2.23K +645 New
Bank of America
36
Bank of America
North Carolina
$1.35K +$38 +11 +2%
UBS Group
37
UBS Group
Switzerland
$1.01K -$14.8K -4,284 -92%
Group One Trading
38
Group One Trading
Illinois
$761 -$818 -237 -45%
Wells Fargo
39
Wells Fargo
California
$725 +$3 +1 +0.4%
SPIA
40
Steward Partners Investment Advisory
New York
$249 +$324 +94 New
HNB
41
Huntington National Bank
Ohio
$186 – – –
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$64 – – –
VCM
43
Versant Capital Management
Arizona
$40 – – –
TWA
44
TCI Wealth Advisors
Arizona
$27 -$35 -10 -50%
AAM
45
AR Asset Management
California
– -$103K -27,900 Closed
BCM
46
Bridgeway Capital Management
Texas
– -$92K -24,922 Closed
VF
47
Virtu Financial
New York
– -$7K -2,000 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
– -$5K -1,480 Closed
Simplex Trading
49
Simplex Trading
Illinois
– -$469 -136 -89%
JP Morgan Chase
50
JP Morgan Chase
New York
– -$17 -5 -4%
1
2
3

MRKR Hedge Fund Activity: Q4 2022 in Review

47 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q4 2022, worth a combined $5.24M — down 31% from $7.56M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MRKR positions and 4 closed out — a net gain of 4 holders — while 10 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $58.4K. The largest seller was AR Asset Management, exiting entirely with an estimated $103K sold.

  • 47 institutional investors held Marker Therapeutics (MRKR) as of Q4 2022, up from 45 in Q3 2022.
  • Funds reported $5.24M of Marker Therapeutics stock for Q4 2022, down 31% quarter-over-quarter.
  • 8 funds opened new Marker Therapeutics positions in Q4 2022 and 4 closed out, a net change of +4 holders.
  • The largest Marker Therapeutics buyer in Q4 2022 was Millennium Management, an estimated $58.4K added.
  • The largest Marker Therapeutics seller in Q4 2022 was AR Asset Management, an estimated $103K sold.

Based on aggregated 13F filings for Q4 2022.